Gilead Sciences Inc logo

Gilead Sciences Inc

BUE:GILD (USA)  
ARS 14227.50 (+0.89%) Sep 22
P/E:
17.51
P/B:
4.48
Market Cap:
ARS 32.71T ($ 93.65B)
Enterprise V:
ARS 39.21T ($ 112.26B)
Volume:
155.00
Avg Vol (2M):
330.00
Also Trade In:
Volume:
155.00
Market Cap ARS:
32.71T
Market Cap $:
93.65B
PE Ratio:
17.51
Avg Vol (2M):
330.00
Enterprise Value ARS:
39.21T
Enterprise Value $:
112.26B
PB Ratio:
4.48

Business Description

Description
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.

Financials (Next Earnings Date:2023-10-27 Est.)

BUE:GILD's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Gilead Sciences Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ARS) 5,055,849.317
EPS (TTM) (ARS) 772.494
Beta 0
Volatility % 44.77
14-Day RSI 56.89
14-Day ATR (ARS) 379.304163
20-Day SMA (ARS) 14374.775
12-1 Month Momentum % 184.94
52-Week Range (ARS) 4719 - 15860
Shares Outstanding (Mil) 1,246.01

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Gilead Sciences Inc Filings

Filing Date Document Date Form
No Filing Data

Gilead Sciences Inc Stock Events

Event Date Price(ARS)
No Event Data

Gilead Sciences Inc Frequently Asked Questions

What is Gilead Sciences Inc(BUE:GILD)'s stock price today?
The current price of BUE:GILD is ARS14227.50. The 52 week high of BUE:GILD is ARS15860.00 and 52 week low is ARS4719.00.
When is next earnings date of Gilead Sciences Inc(BUE:GILD)?
The next earnings date of Gilead Sciences Inc(BUE:GILD) is 2023-10-27 Est..
Does Gilead Sciences Inc(BUE:GILD) pay dividends? If so, how much?
The  Dividend Yield %  of Gilead Sciences Inc(BUE:GILD) is 1.3% (As of Today), Highest Dividend Payout Ratio of Gilead Sciences Inc(BUE:GILD) was 27.2. The lowest was 0.11. And the median was 0.58. The  Forward Dividend Yield % of Gilead Sciences Inc(BUE:GILD) is 1.84%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release